Interestingly, a study on hypoxia-induced upregulation of PFKFB3 reveals that suppressing the upstream target HIF-1α or administering the pharmacological inhibitor PFK158 to decrease PFKFB3 expression can postpone the advancement of atherosclerosis (Wang X, et al., 2024). Here, PFKFB3 is linked to atherosclerosis.